Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis

Journal of Crohn's and Colitis

Volumn 6, Issue 3, 2012, Pages 330-336

  Navaneethan, Udayakumar ^a   Mukewar, Saurabh ^a   Venkatesh, Preethi ^a   Lopez, Rocio ^b   Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Quantitative Health Sciences ^*  (United States)

Author keywords

Clostridium difficile; Colectomy; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; IMMUNOMODULATING AGENT; STEROID;

ADULT; AGE DISTRIBUTION; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMERGENCY WARD; FECES ANALYSIS; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLECTOMY; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; EMERGENCY MEDICAL SERVICES; ENDOSCOPY, GASTROINTESTINAL; FECES; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDNISONE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84858076739     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.09.005     Document Type: Article

References (24)

1. Asha N.J., Tompkins D., Wilcox M.H. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol 2006, 44:2785-2791.
2. Bartlett J.G., Chang T.W., Gurwith M., Gorbach S.L., Onderdonk A.B. Antibiotic-associated pseudo membranous colitis due to toxin-producing clostridia. N Engl J Med 1978, 298:531.
3. McDonald L.C., Killgore G.E., Thompson A., Owens R.C., Kazakova S.V., Sambol S.P., et al. Emergence of an epidemic, toxin gene variant strain of Clostridium difficile responsible for outbreaks in the United States between 2000 and 2004. N Engl J Med 2005, 353:2433-2441.
4. Kazakova S.V., Ware K., Baughman B., Bilukha O., Paradis A., Sears S., et al. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 2006, 166:2518-2524.
5. O'Brien J.A., Lahue B.J., Caro J.J., Davidson D.M. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007, 28:1219-1227.
6. Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep. 2008; 57: 340-3.
7. CDC Severe Clostridium difficile-associated disease in populations previously at low risk-four states. MMWR 2005, 54:1201-1205.
8. Rodemann J.F., Dubberke E.R., Reske K.A., Seo da H., Stone C.D. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:339-344.
9. Issa M., Vijayapal A., Graham M.B., Beaulieu D.B., Otterson M.F., Lundeen S., et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:345-351.
10. Schneeweiss S., Korzenik J., Solomon D.H., Canning C., Lee J., Bressler B. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther 2009, 30:253-264.
11. Nguyen G.C., Kaplan G.G., Harris M.L., Brant S.R. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008, 103:1443-1450.
12. Ananthakrishnan A.N., McGinley E.L., Binion D.G. Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008, 57:205-210.
13. Navaneethan U., Giannella R.A. Thinking beyond the colon-small bowel involvement in Clostridium difficile infection. Gut Pathog 2009, 7.
14. Shen B.O., Jiang Z.D., Fazio V.W., Remzi F.H., Rodriguez L., Bennett A.E., et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008, 6:782-788.
15. Navaneethan U., Shen B. Secondary pouchitis-those with identifiable etiopathogenetic or triggering factors. Am J Gastroenterol 2010, 105:51-64.
16. Meyer A.M., Ramzan N.N., Loftus E.V., Heigh R.I., Leighton J.A. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004, 38:772-775.
17. Mylonaki M., Langmead L., Pantes A., Mylonaki M., Langmead L., Pantes A., Johnson F., Rampton D.S. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Euro J Gastroenterol Hepatol 2004, 16:775-778.
18. Nguyen G.C., Laveist T.A., Gearhart S., Bayless T.M., Brant S.R. Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol 2006, 4:1507-1513.
19. Jodorkovsky D., Young Y., Abreu M.T. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci 2010, 55:415-420.
20. Chiplunker A., Ananthakrishnan A.N., Beaulieu D.B., Naik A.S., Zadvornova Y., Skaros S., et al. Long-term impact of Clostridium difficile on inflammatory bowel disease. Gastroenterology 2009, 136(Suppl 1):S1145.
21. Kariv R., Navaneethan U., Venkatesh P.G., Lopez R., Shen B. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis 2011, 5(1):34-40.
22. Schroeder K.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987, 317:1625-1629.
23. Kelsen J.R., Kim J., Latta D., Smathers S., McGowan K.L., Zaoutis T., et al. Recurrence rate of Clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2011, 17(1):50-55.
24. Navaneethan U., Venkatesh P.G.K., Shen B. Clostridium difficile infection in inflammatory bowel disease-understanding the evolving relationship. World J Gastroenterol 2010, 16(39):4892-4904.